Categories
Activities All-en Hepatitis-B-en Hepatitis-en HepC-en Reports-en

Consultation Meeting on Emerging medications of Hepatitis B and HIV

On 27-28 April 2023, Peduli Hati Bangsa had the opportunity to take part in Access to emerging medications for the prevention and treatment of hepatitis B and HIV consultation meeting organized by TREAT Asia/amfAR in Bangkok. The aim of this meeting was to review morbidity and mortality data specifically in the Hepatitis B region in…

Categories
All-en Hiv-en News-en

TREAT Asia/Amfar policy brief : Expanded Access to Pediatric Dolutegravir

In light of recent U.S. and European regulatory approvals of a dispersible version of pediatric DTG, amfAR’s TREAT Asia program recommends steps that national HIV programs and advocacy groups can take in order to secure access to this medicine as quickly as possible. Read the brief in full here. Source: https://www.amfar.org/news/treat-asia-calls-for-expanded-access-to-pediatric-dolutegravir/

Categories
Activities All-en Hepatitis-B-en Hepatitis-en HepC-en Hiv-en Reports-en

TREAT Asia/amfAR workshop for Hepatitis B

On August 25-26, TREAT Asia / amfAR held a training workshop for the prevention, diagnosis and treatment of Hepatitis B which was held in Bangkok, Thailand. On this occasion, Yayasan Peduli Hati Bangsa together with other organizations in Asia, including the Philippines, Vietnam, India, Nepal and Malaysia, participated in this workshop. The aims of this…